Bringing healthcare into the digital age Digital platform for - - PowerPoint PPT Presentation

2nd Annual Capital Markets Day Steve Curd

CEO, Wanda, Inc.

Bringing healthcare into the digital age

Digital platform for chronic disease management

At the intersection of remote patient monitoring, predictive analytics, and advanced behavioral sciences 2016 Capital Markets Day

“Wanda has created a truly unique platform that engages the most critical variable – the individual. Wanda is the only platform that assesses how a person thinks, feels and behaves, and tailors the recommendation to that unique person. Being part of Wanda is being part of a revolution in healthcare, where the patient is the center, exactly the way it should be.”

• Dr. Suzanne Steinbaum, Medical Director, Wanda

2 2

Who is Wanda?

3

– Cloud-based platform company focused on management of chronic health conditions – Enables more intelligent and efficient clinical decision support, while engaging patients through mobile devices to empower them to remain healthier and out of the hospital – First target conditions: congestive heart failure and cancer, focused on the home health and provider markets – Based on 12 years of R&D and $12M through the UCLA Wireless Health Institute, with

• ngoing UCLA relationship;

portfolio of covering data capture, handling, processing, and analysis; validated by a 1,500 patient clinical trial demonstrating 90% prediction

• f hospitalizations

– $9m NetScientific funding to date – 20 employees, headquartered in San Francisco, led by Steve Curd (United HealthCare, WebMD)

Wanda addresses four massive healthcare trends

Individuals are taking greater personal accountability for their own care, driving demand for consumer- focused digital tools to assist them

4

Personalized Medicine Value-Based Care Aging Population Data to Insight

Care is being pushed to the lowest cost settings, leading to rapid growth in the technically underserved professional home-centered care sector As we live longer and more active lives, the demand for cost-effective chronic condition management is growing substantially Proliferation of low-cost wearables and mobile devices is increasing demand for data collection and analytics to create actionable insights

A serious global healthcare challenge Our focus is on chronic diseases

133m people 45% of the American population have at least

• ne chronic disease

2

• 2. Partnership to Fight Chronic Disease, Wu S, Green A, A Projection
• f Chronic Illness and Cost inflation (2000)

Over 50% More than half the world population lives with chronic disease

1

• 1. National Center for Chronic Disease Prevention

and Health Promotion (2015)

6

This huge healthcare burden could be greatly improved Revenue opportunities

6

$322bn4

Annual cost of diabetes in US $1 in $5 health care dollars is spent caring for people with diabetes

• 4. American Diabetes Association (2015)

86% Most of all the US health care spend is for people with chronic medical conditions $36bn3

Annual cost of COPD in US These costs are expected to rise to $49bn by 2020

• 3. American College of Chest Physicians (2014

$89bn2

Annual cost of cancer in US 33% of cancer deaths worldwide are preventable

• 2. Drugwatch (2015)

$100bn1

Annual cost of Congestive Heart Failure in US 50% of all CHF hospitalizations are avoidable

• 1. Clin. Cardiol. 37, 5, 312-321 (2014)

Our initial focus conditions Future conditions

What has been missing? Full integration of three distinct technologies: Remote collection of patient vitals and symptom data Real-time predictive analytics Patient engagement and behavioral understanding Resulting in data which enables true understanding of disease trajectory

7

We are perfectly positioned The only company offering all the key digital health areas B2B and B2C Our technology is also deployed both business to business and business to consumer

8

Tactio HealthCatalyst ZephyrLIF E CloudMEDX

The proven Wanda platform Personalized medicine meets Inline Analytics™ and advanced behavioral science

9

Key product highlights

10

Wanda CHF: Congestive Heart Failure Clinical Decision Support Software for managing patients with CHF outside of hospital to prevent unnecessary readmissions

25% of patients treated for heart failure (HF) are re-hospitalized within 30 days HF readmission cost is 17B/year in US: 20% of total Medicare expenditure in acute hospital care Remote monitoring has shown minimal benefit 50% back in hospital within 6 months Currently sent home on remote monitoring or nothing CHF affects 6m Americans 670,000 newly diagnosed each year Leading cause of hospitalization for over 65’s

11

Monitoring patients remotely without Wanda

12

Monitoring and engaging patients remotely with Wanda

13

It’s not just what we add, it’s what we take away Wanda was able to predict 90% of CHF readmissions within 1 week leading to them

$2.47bn Estimated cost savings if Wanda is used for CHF

* readmissions savings only

$13,000 Average hospitalisation cost per CHF patients 1,000,000 Average CHF hospital admissions per year 19% Wanda reduction in readmissions 1,000,000 X 0.19 X $13,000 = $2.47bn

CHF hospital readmissions improve with Wanda... ...this clinical validation could of lead to:

15

Business model SaaS model, payment per patient per month – High value targets:

12,000 Home health agencies managing patients in their homes 5,000 Hospitals and health systems managing their own patients

• ut of hospital

16

Proven commercial traction Health Resource Solutions

Health Resource Solutions, Chicago-based home health agency, works with more than 1,000 patients/month, now using Wanda for its patients with CHF HRS is an early adopter among home health agencies turning to digital health to improve the post-discharge process, to gain competitive advantage $60/month/patient with an upfront $225/patient kit Estimated ramp up to >50 patients/month

16

Proven commercial traction Dignity Health

Partnership with Dignity health, the 5th largest health system in the US, and the largest in California First release virtualizes tumor board process by enabling care team collaboration and decision support to improve quality of care for cancer patients Extend within Dignity Health, sign new system later in 2016. Expand relationships to include Wanda for other chronic conditions Include consumer on the platform to participate in decision processes, and to monitor recovery from chronic conditions

17

When coupled with a strong B2B strategy, a direct-to-consumer engagement provides three commercial values:

1

Immediate value for at-risk organizations managing the health

• f large populations

2

Credibility with other business to business prospects

3

Advances richness

• f our data and

analytics capability

How do we differentiate in the consumer health space? Focus first on women’s heart health.

18

19 19

Woman’s heart health

10x more likely to die from heart disease than breast cancer More women die from heart disease than men Two thirds of women who die from a heart attack have no history of chest pain Women’s hearts respond better to lifestyle changes than men’s Wanda is the first and only technology platform company to focus on women’s heart health

20 20

Wanda ‘the companion’ for women’s heart health Consumer facing brand focused

• n engagement, awareness

and health management

Engages the patient and encourages behavior change and personal accountability Empowering caregivers and loved ones to monitor leads to an improved quality

• f life

The Wanda Leadership Team Experienced industry experts

21

Steve Curd CEO Foad Dabiri, Ph.D CTO. Mark Heinemeyer CCO

• Dr. Suzanne Steinbaum

Medical Director.

Scientific Advisory Board: Guiding luminaries

22

• Prof. Majid

Sarrafzadeh

UCLA Computer Science. co- founder UCLA’s center for SMART Health and a co-director

• f BRITE center on Minority

Health Disparities. 500 papers, co-authored 5 books, inventor, patent holder and company founder

• Dr. Janki Shah

UCLA cardiologist & researcher; women’s heart health expert; Director of UCLA’s Women’s Cardiovascular Health Program; Clinical Professor

• Dr. Costanzo

DiPerna

Medical Director Dignity Health Cancer Institute, Medical Director of chest disease; COPD expert; Chief of thoracic surgery

Jeff Moreland

CEO of Patient Engagement Advisors; medication adherence and patient engagement expert

• Dr. Clyde Wesp

Executive Clinical Strategist at Jacobus Consulting; population health, clinical decision support, and public health policy expert

We are focused on...

Chronic disease management Aiming to improve patient quality of life, reduce hospitalization costs and increase the efficiency

• f care delivery

Patented predictive analytics platform Analyses a variety of data sources from users in

• rder to provide predictive insights to all parties

involved in a patients journey Engaging health providers and patients Targeting home health providers and users directly with desktop and mobile applications Series A financing late 2016: up to $20m

23

24 24

Steve Curd Chief Executive Officer steve@yourwanda.com www.yourwanda.com